Executive record
William Todd Horich
Public governance roles and source-backed Claims for this individual.
More
Alpha ID: alpha:person:william-todd-horichVersion: public-0:d751713988987e9331980363e24189ceAs of: 2026-10-05
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
- Executive titleExecutive title: Senior Vice President, Commercial Operations, Marketing, and Market AccessSUPN DEF 14A executive officers
- AI and ML experienceAI and ML experience: not identified in the cited filingSUPN DEF 14A executive officers
- Cybersecurity experienceCybersecurity experience: not identified in the cited filingSUPN DEF 14A executive officers
- Executive companyExecutive at SUPERNUS PHARMACEUTICALS, INC.SUPN DEF 14A executive officers
Biography
Dr. William Todd Horich has served as Senior Vice President, Chief Commercial Officer since March 2026 and joined Supernus in 2010 as its first commercial employee, playing an integral role in building the commercial organization and launching multiple products including Trokendi XR, Oxtellar XR, Qelbree, and ONAPGO. Prior to Supernus, he held positions at Novartis Pharmaceuticals, Vanda Pharmaceuticals, and MedImmune.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- 2026 to end not publishedExecutive title: Senior Vice President, Commercial Operations, Marketing, and Market Access · Organization not publishedSUPN DEF 14A executive officers
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
SUPN DEF 14A executive officers
sec filing · Source published: Apr 30, 2026 · Retrieved: May 5, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Executive company: Executive at SUPERNUS PHARMACEUTICALS, INC. · Claim reviewed: May 5, 2026
- Executive title: Executive title: Senior Vice President, Commercial Operations, Marketing, and Market Access · Claim reviewed: May 5, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-05
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope